Flawed Research, Cursory Peer Review, Perverse Incentives
“Billions of dollars worth of wrong” is how the situation in life science research is described in the Los Angeles Times this week.
Strong words, but supported by findings from Amgen and Bayer HealthCare that may be well known in relatively tiny scientific circles but rarely heard in an outlet such as the Times. It is the largest circulation paper in Cal…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.